DK1231908T3 - Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf - Google Patents
Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse herafInfo
- Publication number
- DK1231908T3 DK1231908T3 DK00951577T DK00951577T DK1231908T3 DK 1231908 T3 DK1231908 T3 DK 1231908T3 DK 00951577 T DK00951577 T DK 00951577T DK 00951577 T DK00951577 T DK 00951577T DK 1231908 T3 DK1231908 T3 DK 1231908T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- donor compound
- patient
- isoform
- protein
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000002840 nitric oxide donor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 2
- 108010029485 Protein Isoforms Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000003190 augmentative effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001605 fetal effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9907442A FR2794647A1 (fr) | 1999-06-11 | 1999-06-11 | Compositions pharmaceutique comprenant du no ou au moins un compose capable de liberer ou d'induire la formation de no dans les cellules |
PCT/FR2000/001612 WO2000076451A2 (fr) | 1999-06-11 | 2000-06-09 | Composition pharmaceutique comprenant du no un compose donneur de no, ou inducteur de la formation de no et son utilisation en therapie |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1231908T3 true DK1231908T3 (da) | 2004-06-14 |
Family
ID=9546698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00951577T DK1231908T3 (da) | 1999-06-11 | 2000-06-09 | Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf |
Country Status (12)
Country | Link |
---|---|
US (1) | US6872751B2 (es) |
EP (1) | EP1231908B1 (es) |
JP (1) | JP2003506320A (es) |
AT (1) | ATE259223T1 (es) |
AU (1) | AU776692B2 (es) |
CA (1) | CA2376302A1 (es) |
DE (1) | DE60008293T2 (es) |
DK (1) | DK1231908T3 (es) |
ES (1) | ES2213032T3 (es) |
FR (1) | FR2794647A1 (es) |
PT (1) | PT1231908E (es) |
WO (1) | WO2000076451A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2847817B1 (fr) * | 2002-11-28 | 2006-11-10 | Centre Nat Rech Scient | Utilisation d'un inhibiteur d'histone deacetylase pour le traitement des dystrophies musculaires |
WO2004073623A2 (en) * | 2003-02-14 | 2004-09-02 | Children's Hospital & Research Center At Oakland | Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
WO2005107384A2 (en) * | 2004-03-31 | 2005-11-17 | Nitromed, Inc. | Methods for treating blood disorders with nitric oxide donor compounds |
WO2007020917A1 (ja) * | 2005-08-18 | 2007-02-22 | The University Of Tokushima | ユートロフィン産生の増強持続剤とこれを用いる加工食品 |
RU2429828C2 (ru) * | 2006-02-03 | 2011-09-27 | Никокс С.А. | Применение нитрооксипроизводного лекарственного средства для лечения мышечной дистрофии |
US9452117B2 (en) * | 2011-06-01 | 2016-09-27 | The Charlotte-Mecklenburg Hospital Authority | Nitrate esters and their use for the treatment of muscle and muscle related diseases |
EP2837390A1 (en) * | 2013-08-15 | 2015-02-18 | Universitäts-Kinderspital beider Basel | Combined Pharmaceutical Preparation for Use in Treating Neuromuscular Disorders |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2149338T3 (es) * | 1993-11-02 | 2000-11-01 | Us Health | Utilizacion de compuestos que liberan oxido nitrico para la fabricacion de un medicamento destinado al tratamiento de lesiones por reperfusion isquemica. |
WO1995028377A1 (en) * | 1994-04-18 | 1995-10-26 | Abbott Laboratories | Guanidine compounds as regulators of nitric oxide synthase |
US5583101A (en) * | 1994-07-15 | 1996-12-10 | Harvard College | Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
US6197745B1 (en) * | 1995-09-15 | 2001-03-06 | Duke University | Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
US6153186A (en) * | 1995-09-15 | 2000-11-28 | Duke University Medical Center | Red blood cells loaded with S-nitrosothiol and uses therefor |
US5789442A (en) * | 1996-01-18 | 1998-08-04 | Schering Aktiengesellschaft | Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents |
WO1997033173A1 (en) * | 1996-03-08 | 1997-09-12 | The Regents Of The University Of California | Muscular dystrophy, stroke, and neurodegenerative disease diagnosis and treatment |
WO1997037644A1 (en) * | 1996-04-05 | 1997-10-16 | The General Hospital Corporation | Treatment of a hemoglobinopathy |
DE29709820U1 (de) * | 1996-06-10 | 1997-07-31 | NUTREND, s.r.o., Olomouc | Lebensmittel-Spezialzusatz |
DE69731758T2 (de) * | 1996-09-27 | 2005-12-15 | The United States Government As Represented By The Department Of Health And Human Services | O2-arylate oder o2 glycosyiate 1-substituierte diazen-1-ium-1,2 diolate und o2-substituierte 1 (2-carboxylate) pyrolidin-1-yl diazen-1-ium-1,2-diolate |
NO310618B1 (no) * | 1997-04-10 | 2001-07-30 | Ono Pharmaceutical Co | Kondenserte piperidinforbindelser, fremstilling og anvendelse derav, samt preparater omfattende slike forbindelser |
DE69842142D1 (de) * | 1997-07-03 | 2011-04-07 | Us Gov Health & Human Serv | Stickoxid freistetzende amidin- und enaminverwandte diazeniumdiolate, zubereitungen und verwendungen davon und verfahren zu ihrer herstellung |
AU3139500A (en) * | 1999-03-11 | 2000-09-28 | University Of Manitoba | Modulation of skeletal muscle precursor cell activation |
US6472390B1 (en) * | 2001-11-13 | 2002-10-29 | Duke University | Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
-
1999
- 1999-06-11 FR FR9907442A patent/FR2794647A1/fr active Pending
-
2000
- 2000-06-09 JP JP2001502791A patent/JP2003506320A/ja active Pending
- 2000-06-09 DE DE2000608293 patent/DE60008293T2/de not_active Expired - Fee Related
- 2000-06-09 EP EP20000951577 patent/EP1231908B1/fr not_active Expired - Lifetime
- 2000-06-09 AU AU64473/00A patent/AU776692B2/en not_active Ceased
- 2000-06-09 PT PT00951577T patent/PT1231908E/pt unknown
- 2000-06-09 WO PCT/FR2000/001612 patent/WO2000076451A2/fr active IP Right Grant
- 2000-06-09 DK DK00951577T patent/DK1231908T3/da active
- 2000-06-09 CA CA002376302A patent/CA2376302A1/fr not_active Abandoned
- 2000-06-09 AT AT00951577T patent/ATE259223T1/de not_active IP Right Cessation
- 2000-06-09 ES ES00951577T patent/ES2213032T3/es not_active Expired - Lifetime
-
2002
- 2002-04-29 US US10/133,435 patent/US6872751B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2794647A1 (fr) | 2000-12-15 |
AU776692B2 (en) | 2004-09-16 |
EP1231908B1 (fr) | 2004-02-11 |
WO2000076451A2 (fr) | 2000-12-21 |
CA2376302A1 (fr) | 2000-12-21 |
JP2003506320A (ja) | 2003-02-18 |
EP1231908A2 (fr) | 2002-08-21 |
PT1231908E (pt) | 2004-06-30 |
AU6447300A (en) | 2001-01-02 |
DE60008293D1 (de) | 2004-03-18 |
US20020164383A1 (en) | 2002-11-07 |
ES2213032T3 (es) | 2004-08-16 |
DE60008293T2 (de) | 2005-01-13 |
US6872751B2 (en) | 2005-03-29 |
ATE259223T1 (de) | 2004-02-15 |
WO2000076451A3 (fr) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69930739D1 (de) | Transdermale verwendung von sekretin zur behandlung von autismus | |
HK1097449A1 (en) | Methods for in vivo delivery of biologics and compositions useful therefor | |
BR0110767A (pt) | Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina | |
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
NO20024646D0 (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
ES2173858T3 (es) | Analogos de huperzina a. | |
BR0014826A (pt) | Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm | |
DK1231908T3 (da) | Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf | |
ATE234082T1 (de) | Adenosin enthaltendes arzneimittel | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
BR0112131A (pt) | Composições farmacêuticas e métodos para uso | |
ATE285773T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
BRPI0409790A (pt) | 7-azaindóis e seu uso como terapêuticos | |
ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
DE3380923D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen. | |
DE60007074D1 (de) | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung | |
DE60028207D1 (de) | Transdermales therapeutisches system zur verabreichung von calciumantagonisten | |
BR0211323A (pt) | Combinação de ingredientes ativos, uso de uma combinação de ingredientes ativos e método de terapia farmacológica de dependência de nicotina | |
HN2000000072A (es) | Amidas de acidos fenilciclohexanocarboxilicos sustituidos | |
PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan | |
ES2058316T3 (es) | Procedimiento para la obtencion de un medicamento antitusigeno. | |
UA29106A (uk) | Спосіб лікування вібраційної хвороби | |
ES2127133B1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. |